Drug
PH 797804 clinical trials
- studies test it
- 15
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
15 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 0
Often tested with
Tested in the same studies.
Naproxen (1) · Moxifloxacin (1) · Erythromycin (1) · Pf-03715455 (1)
Studies
Open first, then newest update. How each study uses PH 797804 is read from its arms, and is right about nine times in ten.
Testing it · 15
- An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid ArthritisCompletedPhase 2PfizerNCT00383188Written as PH-797804
- A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking MethotrexateCompletedPhase 2PfizerNCT00620685Written as PH-797804
- A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedPhase 2PfizerNCT00559910Written as PH-797804
- Relative Bioavailability and Food Effect StudyWithdrawnPhase 1PfizerNCT00827515Written as PH797804
- Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium BromideCompletedPhase 2PfizerNCT01543919Written as PH-797804
- Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the KneeCompletedPhase 2PfizerNCT01102660Written as PH-797804
- PH-797804 LPS Study in Healthy VolunteersCompletedPhase 1PfizerNCT02084485Written as PH-797804
- A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804WithdrawnPhase 1PfizerNCT01924650Written as PH-797804
- A Study to Investigate the Effect of PH-797804 on QTc IntervalCompletedPhase 1PfizerNCT01862887Written as PH-797804
- Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate CombinationCompletedPhase 2PfizerNCT01321463Written as PH-797804
- A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804CompletedPhase 1PfizerNCT01589614Written as PH-797804
- A Study To Investigate The Effect Of Food On The Pharmacokinetics Of PH-797804CompletedPhase 1PfizerNCT01479647Written as PH-797804
- Single Dose Lipopolysaccharide (LPS) Study In Healthy VolunteersCompletedPhase 1PfizerNCT01314885Written as PH-797804
- PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic NeuralgiaCompletedPhase 2PfizerNCT00614705Written as PH-797804
- A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804CompletedPhase 1PfizerNCT01226693Written as PH-797804 material sparing tablet
Codes
What other systems call PH 797804 · ClinicalTrials.gg INT005468
- Wikidata Q27088355ph-797804One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27088355 | ph-797804 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.